Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection

Say goodbye to brain scans! How blood tests are set to revolutionize Alzheimer’s detection

A groundbreaking study by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has revealed that certain blood tests are now accurate enough to be used in clinical settings for detecting Alzheimer’s disease. This new research suggests these blood tests could replace more invasive procedures like spinal taps and brain scans for many […]

Quanterix launches diagnostic test aiding early Alzheimer’s detection

Quanterix launches diagnostic test aiding early Alzheimer’s detection

Quanterix, a biomarker detection firm powering scientific research and breakthrough diagnostics, has introduced LucentAD, a new test designed to aid in the evaluation of patients exhibiting cognitive symptoms indicative of early Alzheimer’s disease (AD). This test allows healthcare providers to quickly assess the likelihood of a patient exhibiting amyloid pathology, a significant marker of Alzheimer’s […]